meglitinide has been researched along with Pemphigoid, Bullous in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Geng, R; Huang, L; Huang, W; Jiang, Y; Li, H; Liu, Y; Tang, Z | 1 |
1 other study(ies) available for meglitinide and Pemphigoid, Bullous
Article | Year |
---|---|
Bullous Pemphigoid and Diabetes medications: A disproportionality analysis based on the FDA Adverse Event Reporting System.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Benzamides; Case-Control Studies; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Male; Middle Aged; Pemphigoid, Bullous; Pharmacovigilance; Retrospective Studies; Sulfonylurea Compounds; United States; United States Food and Drug Administration | 2021 |